Combined Serum DKK3 and Circulating CD133 Cells as Prognostic Biomarkers for Ovarian Cancer Patients.

Xiao-Cui NieFang HeChong LanJu-Min NiuPu Xia

Published in: OncoTargets and therapy (2021)

Both serum DKK3 levels and circulating CD133+ tumor cells can be used as prognostic markers for patients with ovarian cancer.